Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 16Phase 2/3 5Phase 3 3Phase NA 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 2Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Glioma 1Glioblastoma 1Endometrial Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 4Sirolimus 2Magnetic Resonance Spectroscopy 2Etoposide 2venetoclax 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1daratumumab 1copanlisib 1alovudine 1X-Rays 1Whole-Body Irradiation 1Vincristine 1Transplantation Conditioning 1Transplantation 1Stem Cell Transplantation 1Spinal Puncture 1Specimen Handling 1Pneumococcal Vaccines 1Photopheresis 1Phantoms, Imaging 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Mycophenolic Acid 1Methotrexate 1Mesna 1Mesenchymal Stem Cell Transplantation 1Leukapheresis 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Dasatinib × Clear all
NCT04603872 2020-10-28

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Zhejiang University

Phase EARLY_PHASE1 Recruiting
120 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡